Narrative review of TCM active ingredients for asthenozoospermia notes current knowledge gaps and limitations.

This narrative review focuses on the potential role of Traditional Chinese Medicine (TCM) active ingredients, specifically flavonoids, polysaccharides, saponins, and phenols, for the condition of asthenozoospermia. The scope of the article is limited by the absence of reported data on the study population, sample size, setting, or specific comparators. Furthermore, no primary or secondary outcomes, follow-up durations, or adverse event rates are provided within the source text.

The authors synthesize the existing literature to identify substantial gaps in current knowledge regarding TCM active components for asthenozoospermia. They explicitly note the current limitations of TCM in this specific area, emphasizing that the evidence base remains incomplete. Because the source is a narrative review rather than a systematic review or meta-analysis, no pooled effect sizes or quantitative efficacy data are presented.

The review concludes that while these ingredients warrant attention, the evidence is insufficient to support immediate clinical adoption. The authors suggest that the current state of knowledge serves primarily as a reference for future research directions. Practitioners should interpret these findings with caution, recognizing the lack of reported safety data and the absence of causal claims in this observational synthesis.